The percentage of poll respondents who endorsed specific strategies in response to the following question: “Do you take or do any of the following to maintain or improve your memory?” Responses are grouped by perceived likelihood of developing dementia (somewhat/very likely vs not likely). A χ2 test was used to compare particular strategies endorsed by perceived likelihood of developing dementia. All comparisons were nonsignificant with the exception of discussion with a physician, which was endorsed more frequently by those who believed they were at least somewhat likely to develop dementia (7.1% [95% CI, 5.1%-9.8%] vs 3.6% [95% CI, 2.2%-5.7%]; P = .02).
Customize your JAMA Network experience by selecting one or more topics from the list below.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Maust DT, Solway E, Langa KM, et al. Perception of Dementia Risk and Preventive Actions Among US Adults Aged 50 to 64 Years. JAMA Neurol. 2020;77(2):259–262. doi:10.1001/jamaneurol.2019.3946
Disease-preventing or disease-modifying treatments do not exist for Alzheimer disease or other dementias. Adults may be unaware of strategies to reduce their risk1 and resort to marketed but ineffective options, such as ginkgo biloba or vitamin E. While these so-called treatments are relatively inexpensive, new preventive therapies may not be. Thus, individuals overestimating their risk of developing dementia could lead to inappropriate use and excessive costs.2 This analysis explores how adults aged 50 to 64 years estimate their lifetime risk of dementia and the risk-reducing strategies they pursue.
The University of Michigan National Poll on Healthy Aging (NPHA) is a nationally representative survey of adults ages 50 to 80 years, sponsored by AARP and Michigan Medicine. The NPHA uses KnowledgePanel (Ipsos Public Affairs LLC), a probability-based panel of the civilian, noninstitutionalized US population. This survey was fielded in October 2018; questions for this analysis were asked of respondents aged 50 to 64 years. The University of Michigan institutional review board reviewed this study and deemed it exempt from human subjects review because it was a study of deidentified respondents. The requirement for informed consent was therefore waived.
Along with demographic information and self-reported health status, respondents were asked, “How likely are you to develop dementia during your lifetime?” (with the possible answers being “very likely,” “somewhat likely,” and “not likely”); “Have you ever discussed ways to prevent dementia with your doctor?”; and about 4 specific strategies to “maintain or improve your memory” (with the possible answers being yes or no).
The outcome of interest was perceived likelihood of developing dementia (very/somewhat likely vs not likely). The association of respondent characteristics with perceived likelihood of developing dementia was examined with logistic regression. The final adjusted model was used to determine the expected probability of respondents’ perceived likelihood of developing dementia. Finally, memory-preserving strategies were examined overall and by perceived dementia likelihood.
Analyses used poststratification weights to draw national inferences and were performed using Stata version 15.1 (StataCorp LLC). A 2-tailed P < .05 was considered statistically significant.
Among 1019 respondents aged 50 to 64 years, 48.5% (95% CI, 45.3%-51.7%) reported they were at least somewhat likely to develop dementia (those answering “somewhat”: 44.3% [95% CI, 41.1%-47.5%]; those answering “very,” 4.2% [95% CI, 3.1%-5.8%]). In adjusted analyses, non-Hispanic black respondents were significantly less likely to believe they may develop dementia (adjusted odds ratio, 0.51 [95% CI, 0.32-0.81]; P = .01; Table). Respondents who rated their mental health as fair or poor reported a higher likelihood of developing dementia (adjusted odds ratio, 2.30 [95% CI, 1.19-4.47]; P = .01) although those with similarly rated physical health did not (adjusted odds ratio, 1.46 [95% CI, 0.93-2.28]; P = .10).
Only 5.2% (95% CI, 4.0%-6.8%) of respondents had discussed dementia prevention with their physician (Figure). In contrast, 31.6% (95% CI, 28.7-34.6) endorsed using fish oil or ω-3 fatty acids, and 39.2% (95% CI, 36.1%-42.4%) used other vitamins or supplements. Discussion with a physician was the only strategy that varied by perceived likelihood of developing dementia, being more common among respondents with a higher perceived likelihood (7.1% [95% CI 5.1%-9.8%]) vs those with a lower perceived likelihood (3.6% [95% CI 2.2%-5.7%]; P = .02).
Among US adults aged 50 to 64 years in this poll, nearly 50% believe they are at least somewhat likely to develop dementia. Non-Hispanic black American individuals have a higher prevalence of dementia than other racial or ethnic groups,3 but in this survey, they perceived their risk as lower relative to other groups. Those with fair to poor physical health did not accurately perceive that their likelihood of developing dementia was potentially higher than respondents with very good or excellent physical health. In contrast, fair to poor mental health had the largest association with perceived likelihood of dementia, even though less evidence suggests that poor mental health is causally linked with dementia.4
Poll respondents report engaging in a variety of strategies to maintain or improve memory that are not evidence based. While managing chronic medical conditions, such as diabetes or cardiovascular disease, could reduce dementia risk,4 few respondents appear to have discussed this with their physician.
Given repeated failures of disease-preventing or disease-modifying treatments for dementia, interest in treatment and prevention have shifted earlier in the disease process. Adults in middle age may not accurately estimate their risk of developing dementia, which could lead to both overuse and underuse if preclinical dementia treatments become available. Policy and physicians should emphasize current evidence-based strategies of managing lifestyle and chronic medical conditions to reduce the risk of dementia.5
Corresponding Author: Donovan T. Maust, MD, MS, Department of Psychiatry, University of Michigan, 2800 Plymouth Rd, NCRC 016-226W, Ann Arbor, MI 48109 (firstname.lastname@example.org).
Published Online: November 15, 2019. doi:10.1001/jamaneurol.2019.3946
Correction: This article was corrected on December 20, 2019, to fix the phrase “Respondents who rated their physical or mental health as fair or poor reported a higher likelihood of developing dementia.” This phrase should have mentioned mental health only, omitting physical health.
Author Contributions: Drs Maust and Malani had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Maust, Solway, Kullgren, Singer, Malani.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Maust, Malani.
Critical revision of the manuscript for important intellectual content: Maust, Solway, Langa, Kullgren, Kirch, Singer.
Statistical analysis: Maust, Kirch.
Obtained funding: Langa, Malani.
Administrative, technical, or material support: Solway, Kullgren, Singer, Malani.
Supervision: Maust, Malani.
Conflict of Interest Disclosures: Dr Maust reported grants from the National Institute on Aging, the National Institute on Drug Abuse, and the Department of Veterans Affairs during the conduct of the study. Dr Solway reported grants from AARP during the conduct of the study. Dr Langa reported grants from the National Institute on Aging during the conduct of the study and grants from Alzheimer's Association outside the submitted work. Dr Kullgren reported grants from AARP during the conduct of the study; personal fees from SeeChange Health, HealthMine, Kaiser Permanente Washington Health Research Institute, Robert Wood Johnson Foundation, American Diabetes Association, AbilTo Inc, and Kansas City Area Life Sciences Institute outside the submitted work; and support from the Department of Veterans Affairs, Veterans Health Administration, and the Health Services Research and Development Service. Dr Kullgren is a VA Health Services Research and Development Service Career Development awardee at the Veterans Affairs Ann Arbor Healthcare System. Dr Kirch reported other support from AARP during the conduct of the study. Dr Malani reported grants from AARP during the conduct of the study. No other disclosures were reported.
Funding/Support: This research was supported by AARP, Michigan Medicine, and grants R01AG056407 (Dr Maust), P30AG053760 (Dr Langa), and P30AG024824 (Dr Langa) from the National Institute on Aging.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Meeting Presentation: This paper was presented at the Gerontological Society of America Annual Meeting; November 15, 2019; Austin, Texas.
Disclaimer: The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the US government.